Posted on March 21, 2017
Join Eric S. Kastango, RPh, MBA, FASHP and Joe Coyne, RPh to review the requirements of USP <800> as it relates to handling and storage of hazardous drugs listed in Tables 1-3 within the 2016 NIOSH List of Hazardous Drugs.
Learn how to systematically conduct an assessment of your facility’s risk as it relates to the handling and storage of hazardous drugs. The webinar will be conducted on:
April 12, 2017
12 pm EST
USP <800> Hazardous Drugs – Handling in Healthcare Settings sets the standard for protecting patients, health care personnel, and the environment. It is designed to minimize the risk of exposure to HDs for healthcare personnel (…a different issue than the EPA requirements for hazardous materials – some of which are drugs – that are harmful to the environment).The National Institute for Occupational Health and Safety (NIOSH) maintains a list of hazardous drugs (HDs, which include those drugs that have any of the following characteristics:
Drugs are listed in one of three tables:
Table 1 – includes antineoplastics
Table 2 – includes non-antineoplastics
Table 3 – includes HDs that are on the list only because of reproductive toxicity
Chapter <800> defines the safe strategies for receiving, transporting, storing, compounding, administering, and disposing of hazardous drugs in healthcare settings. Entities can either implement all of the containment strategies or work practices for all of the drugs on the NIOSH list OR for those agents that are not antineoplastic, the entity may establish alternative containment strategies and/or work practices to protect employees.
Deciding on an Approach
If you choose not to do an Assessment of Risk, then you must handle all dosage forms of all the HDs using all the containment strategies and work practices listed in Chapter <800>. Every pharmacy and healthcare setting needs to evaluate the list of HDs, even if only those drugs on tables 2 and 3 are handled, and even if only oral forms are handled.
If you choose to do an Assessment of Risk, there are some limitations:
The drugs on the list that can be considered for an Assessment of Risk are
Your list must be specific to the drugs and dosage forms that you handle.
Performing an Assessment of Risk
Register today for a free webinar with Eric S. Kastango, RPh, MBA, FASHP on March 29, 2017 to learn about the requirements of USP <800> as it relates to handling and storage of hazardous drugs listed in Tables 1-3 within the 2016 NIOSH List of Hazardous Drug. After participating in this webinar attendees will understand how to systematically evaluate how to conduct an Assessment of Risk.
(Please note: Pharmacy OneSource is not an accredited organization so we cannot provide CE credit for the webinar at this time.)
Written for clinicians